Medicare Enrolled
Dr. Clifford Gluck, M.D.
Urology Physician · Dorchester Center, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gluck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gluck?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gluck
Dr. Clifford Gluck is an urology physician in Dorchester Center, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gluck performed 128,379 Medicare services across 3,343 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gluck received a total of $5,326 from 44 pharmaceutical and/or device companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gluck is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in MA
$5,326 industry payments
Medicare Practice Summary
Medicare Utilization ↗128,379
Medicare services
Top 0% in MA for urology physician
3,343
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,419 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
75,000 | $1 | $4 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
43,600 | $0 | $0 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
4,121 | $34 | $97 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
951 | $69 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
436 | $89 | $336 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
426 | $70 | $238 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
413 | $3 | $25 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
395 | $8 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
323 | $12 | $38 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
317 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
317 | $34 | $100 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
317 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
317 | $34 | $100 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
316 | $34 | $100 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
241 | $4 | $12 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $43 | $149 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
95 | $3 | $12 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
92 | $204 | $655 |
| Urethral dilation, female, subsequent A procedure to widen the urethra in a female patient during a follow-up visit. This is performed after an initial dilation has already taken place. |
92 | $59 | $197 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $129 | $437 |
| Injection, garamycin, gentamicin, up to 80 mg | 70 | $2 | $8 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
56 | $49 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $26 | $89 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
41 | $8 | $25 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
38 | $269 | $878 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
29 | $105 | $426 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $143 | $473 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
26 | $45 | $150 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $194 | $650 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
20 | $495 | $1,584 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
16 | $61 | $207 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $624 | $1,993 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,326
Total received (2018-2024)
Avg $761/year across 7 years
Top 26% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
227
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,326 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,054
2023
$844
2022
$781
2021
$528
2020
$378
2019
$347
2018
$1,393
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edap Technomed Inc
$450
Antares Pharma, Inc.
$94
Sumitomo Pharma America, Inc.
$75
Janssen Biotech, Inc.
$60
Astellas Pharma US Inc
$57
Myriad Genetic Laboratories, Inc.
$51
Ferring Pharmaceuticals Inc.
$46
Endo Pharmaceuticals Inc.
$41
ABBVIE INC.
$36
Endo USA, Inc.
$36
180 Medical, Inc.
$35
Tolmar, Inc.
$27
Krystal Biotech Inc
$17
PFIZER INC.
$14
ConvaTec Inc.
$14
Top 3 companies account for 58.7% of 2024 payments
All-time payments by company (2018-2024) ›
EDAP TECHNOMED INC
$1,102
Astellas Pharma US Inc
$823
PFIZER INC.
$602
Edap Technomed Inc
$450
Endo Pharmaceuticals Inc.
$345
Antares Pharma, Inc.
$298
UROVANT SCIENCES INC
$151
Sumitomo Pharma America, Inc.
$139
Janssen Biotech, Inc.
$133
Acerus Pharmaceuticals Corporation
$101
ABBVIE INC.
$91
Myriad Genetic Laboratories, Inc.
$82
Tolmar, Inc.
$81
180 Medical, Inc.
$77
Rochester Medical Corporation
$59
Allergan, Inc.
$51
Myovant Sciences Inc.
$51
Boston Scientific Corporation
$47
Ferring Pharmaceuticals Inc.
$46
Allergan Inc.
$41
AbbVie, Inc.
$37
Olympus America Inc.
$37
Medtronic, Inc.
$36
Endo USA, Inc.
$36
BOSTON SCIENTIFIC CORPORATION
$35
Blue Earth Diagnostics Limited
$32
TherapeuticsMD, Inc.
$31
TOLMAR Pharmaceuticals, Inc.
$29
Axonics, Inc.
$28
Laborie Medical Technologies Corp.
$26
Clarus Therapeutics Inc.
$23
Cook Medical LLC
$23
KARL STORZ Endoscopy-America
$21
Otsuka America Pharmaceutical, Inc.
$20
C. R. BARD, INC. & SUBSIDIARIES
$17
Krystal Biotech Inc
$17
Sun Pharmaceutical Industries Inc.
$14
Medtronic USA, Inc.
$14
AcelRx Pharmaceuticals, Inc.
$14
Hollister Incorporated
$14
ConvaTec Inc.
$14
Metuchen Pharmaceuticals
$13
NxThera, Inc.
$12
Axonics Modulation Technologies, Inc.
$12
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
24FR BIPLR COAG ELECTRDE · ADSTILADRIN · AVEED · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX - UROLOGY · Bulkamid · CURE CATHETER · DSUVIA · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GENTLECATH GLIDE · IMVEXXY · INTERSTIM · JATENZO · JYNARQUE · Lupron · MAGIC3 · MAGIC3 INTERMITTENT CATHETER · MYRBETRIQ · MYRISK · Myrbetriq · NCIRCLE · NOCDURNA · Natesto · ONLI · ORGOVYX · OTREXUP · PKG/6 · PRECISETUMOR · PROLARIS · REZUM · Rezum · SOLYX · STERILE · Stendra · TLANDO · TOVIAZ · VYJUVEK · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
206
Per 100K population
26.3
County median income
$92,859
Nearest hospital
CARNEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gluck is a mixed practice specialist, with above-average Medicare volume (top 0% in MA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gluck experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Gluck performed 75,000 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gluck receive payments from pharmaceutical companies?
Yes. Dr. Gluck received a total of $5,326 from 44 companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gluck's costs compare to other urology physicians in Dorchester Center?
Dr. Gluck's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gluck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dorchester Center
Browse urology physicians in Dorchester Center ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
EDAP TECHNOMED INC Payments to Doctors
See all physicians who received payments from EDAP TECHNOMED INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology